ALDX - Aldeyra Therapeutics, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics Inc is biotechnology company focused on the development of products for inflammation, inborn errors of metabolism, and other diseases, related to endogenously generated toxic and pro-inflammatory chemical species known as aldehydes.
IPO Date: April 28, 2014
Sector: Healthcare
Industry: Biotech
Related Tickers:
AMGN GILD VRTX REGN MRNA ARGX ONC IQV BIIB RVMD
Market Cap: $50.7M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.22 | 3.70%
Avg Daily Range (30 D): $0.04 | 5.63%
Avg Daily Range (90 D): $0.05 | 4.40%
Institutional Daily Volume
Avg Daily Volume: .6M
Avg Daily Volume (30 D): .94M
Avg Daily Volume (90 D): 1.06M
Trade Size
Avg Trade Size (Sh.): 150
Avg Trade Size (Sh.) (30 D): 272
Avg Trade Size (Sh.) (90 D): 266
Institutional Trades
Total Institutional Trades: 455
Avg Institutional Trade: $1.71M
Avg Institutional Trade (30 D): $2.09M
Avg Institutional Trade (90 D): $1.71M
Avg Institutional Trade Volume: .25M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.9M
Avg Closing Trade (30 D): $1.01M
Avg Closing Trade (90 D): $1.01M
Avg Closing Volume: 269.49K
 
News
Oct 15, 2026 @ 1:33 PM
RARE's Fayuvi Approval Spurs Second PRV Sale Worth...
Source: Na
Oct 14, 2026 @ 12:59 PM
Here's Why You Should Add ANRO Stock to Your Portf...
Source: Na
Oct 14, 2026 @ 12:52 PM
Syndax Stock Falls 16% as Phase II Fibrosis Study ...
Source: Na
Oct 12, 2026 @ 3:24 PM
Prime Medicine Stock Rallies Nearly 26% in a Month...
Source: Na
Oct 12, 2026 @ 2:55 PM
PMVP Stock Rises 19% in 3 Months: Here's What You ...
Source: Na